European Pharmaceutical Review

SEPTEMBER 14, 2023

Ultimately, this puts European businesses at a competitive disadvantage compared to other companies worldwide. Once adopted by the Council, the regulatory proposals are planned to come into force on 1 July 2028 (for BEFIT) and on 1 January 2026 (for the transfer pricing proposal).

Competition 97

Competition Pharma Pharmaceutical 97

pharmaphorum

SEPTEMBER 30, 2022

Merck & Co has been fighting to defend its blockbuster type 2 diabetes therapy Januvia from generic competition for years, and a new judgment looks set to protect its third biggest-selling drug for another few years. That challenged the ‘708 patent – which expires in November 2026 – as well as one other (No.

Marketing 59

Marketing Sales Competition FDA 59

European Pharmaceutical Review

AUGUST 22, 2022

However, China and India are set to be fierce competition over the next decade, with 30 percent of respondents suggesting they would offshore >50 percent of clinical trials and operations to India, China or other lower-cost countries over the next five years.

Biopharma 98

Biopharma Manufacturing Marketing Competition 98

PM360

SEPTEMBER 21, 2023

Attention deficit hyperactivity disorder (ADHD) drug Vyvanse (lisdexamfetamine dimesylate) , manufactured by Takeda, also is facing generic competition. In the respiratory area with inhalers, it’s tough to get drugs approved, so the competition comes slowly,” he said. Starting in 2026, the provision will affect 10 Part D drugs.

Management 105

Management Manufacturing Sales Competition 105

Pharmaceutical Technology

MAY 11, 2023

GlobalData’s Internet of Things (IoT) Market report helps keep abreast of the latest trends in internet of things, market opportunity forecast and the competitive landscape. To further understand GlobalData's analysis on Internet of Things (IoT) Market Size, Share, Trends Analysis, and Segment Forecast 2021-2026 buy the report here.

Media 52

Media Pharma Competition Marketing 52

Pharmaceutical Technology

MAY 29, 2023

It provides forward-looking analysis of the market including market sizing up to 2026, segmentation by application, potential growth opportunities, and competitive pr Buy the report here.

Pharmaceutical 52

Pharmaceutical Marketing Competition Medicine 52

PM360

APRIL 7, 2023

However, we expect drugs without strong therapeutic alternatives to have an advantage in negotiations, while drugs in highly competitive classes will be negotiating from a weaker position. Expect the nine competitors to explore Kotler’s 4Ps of Marketing to gain share in this lucrative and competitive marketplace.

Manufacturing 97

Manufacturing Insurance Marketing Government 97

pharmaphorum

JANUARY 10, 2023

billion by 2026, according to research by the Business Research Company. If you have to wait to extract meaning from your data then you won’t be competitive enough. “A I believe huge opportunities await organisations that properly leverage their data.”. billion in 2021 to $9.23 About half raised their hands.

Marketing 98

Marketing Pharma Healthcare Healthcare 98

pharmaphorum

OCTOBER 17, 2022

It remains to be seen whether the data from VALOR will convince the regulator to grant conditional approval while it waits for results from a confirmatory phase 3 trial (ATLAS ) in SOD1-ALS, which is due to generate results in 2026.

FDA 52

FDA Prospecting Competition Safety 52

Clarivate

OCTOBER 25, 2023

The initial list, which takes effect in 2026, has the potential to roil formularies since it includes a mix of high-volume, preferred brands and a group of high-cost specialty drugs for autoimmune conditions (psoriasis) and cancer. exclusions exist for orphan drug designation and biosimilar competition ).

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Clarivate

AUGUST 27, 2024

FDA approval in the fourth quarter, with Johnson & Johnson’s Varipulse system close behind, so competition will pick up. Abbott’s Volt should join the party in early 2026. Still, analysts and providers project that Farapulse, which has more than 70% of the global market today, will continue to dominate at least through 2025.

Marketing 52

Marketing FDA Competition Medical 52

Spotio

JUNE 6, 2022

For example : SPOTIO’s Lead Machine gives reps and managers a competitive advantage because they are able to quickly build detailed customer profiles and map territories filled with qualified prospects in minutes. With so much potential, comes a lot of competition. The average person receives 147 emails every day!

Sales 111

Sales Prospecting B2B Sales Leads 111

Pharmaceutical Technology

JANUARY 10, 2023

Type 2 diabetes (T2D) is a crowded and competitive landscape with multiple “me-too,” generic and biosimilar drugs entering the market, with market growth primarily driven by an increasing prevalent population across nine major markets (9MM: US, France, Germany, Italy, Spain, UK, Japan, China, and India).

Marketing 52

Marketing Physicians Sales Leads 52

Spotio

DECEMBER 30, 2024

Gartner predicts that by 2026, 75% of high-growth organizations will have adopted a RevOps model, up from less than 30% in 2024. Why Your Business Needs a Revenue Operations Strategy A RevOps strategy is more than a nice to haveits a vital component for driving success and maintaining a competitive edge. 13% saw faster revenue growth.

Sales 52

Sales Prospecting CRM Leads 52

PM360

FEBRUARY 1, 2024

Those numbers are predicted to increase to 84% and 93%, respectively, by 2026 while the total annual spend for these trials across all phases is expected to increase significantly in the next few years.

Recruitment 52

Recruitment Healthcare Healthcare Management 52

European Pharmaceutical Review

FEBRUARY 7, 2023

However, a delicate balance will need to be struck between the need for affordable and accessible medicinal products and the desire to foster innovation and competitiveness in the EU. of the MDR and Article 110.4 of the IVDR for medical devices and in vitro diagnostic medical devices (IVDs).

Medical 117

Medical Government Marketing Medicine 117

Clarivate

APRIL 24, 2023

Oak Street has 169 locations across 21 states and expects to nearly double its size to 300 centers by 2026. billion deal to acquire Oak Street Health, a value-based primary-care company focused on treating Medicare patients. In January 2023, VillageMD acquired Summit Health for $8.9

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

Spotio

APRIL 21, 2023

Recent research shows that the hardware as a service market (HaaS) should reach $300+ billion in 2026. While the demand is high, the competition is fierce. Do you sell POS systems? Then you have a lot to look forward to. Other studies predict the POS space, specifically, to grow by 6.9% To give yourself an edge, invest in SPOTIO.

Sales 52

Sales Prospecting Leads Sales pitches 52

pharmaphorum

JUNE 29, 2022

COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. She holds a degree in Neuroscience from the University of Nottingham.

Doctors 59

Doctors Medicine Marketing Sales 59

Evolve Your Success

JANUARY 24, 2023

If it’s 2026 and you’re reading this, this happened in 2023. This determination led me to an incredibly fulfilling career as an OB registered nurse and opened the door to my ultimate dream of transferring my patient-centered skills to a career in medical sales where my charisma, drive, and competitive nature can fully thrive.

Medical sales 130

Medical sales Sales Medical Education 130

PM360

SEPTEMBER 28, 2022

Maximum Fair Prices published: The first round of negotiated Maximum Fair Prices will be published in August 2024, scheduled to take effect in 2026. Plan bids will reflect negotiated prices for the first time in 2025 (for the 2026 plan year), affecting formulary and coverage strategies. Enterprise view of portfolio is critical.

Manufacturing 97

Manufacturing Government Prescription Marketing 97

Clarify Health

FEBRUARY 6, 2024

That way, they can continue to grow membership and thrive against the competition. In 2026, payers will need to send prior authorization decisions within 72 hours for urgent requests and seven business days for standard requests. These changes are designed to make care easier to access for enrollees.

Networking 52

Networking Insurance Government Management 52

Pharmaceutical Technology

MAY 25, 2023

Analysis estimates that the oncolytic virus market will reach $1 billion by 2026. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Safety 52

Safety Patients Prospecting Marketing 52

Infuse Medical

MARCH 12, 2025

In todays highly competitive market, immersive medical sales technology is no longer optionalits essential. trillion by 2026 , according to IDC. This presents a massive opportunity for medical sales teams to integrate immersive medical sales technology into their sales strategies and stay ahead of the competition.

Sales technology 130

Sales technology Medical sales Sales Medical 130

Clarivate

AUGUST 20, 2024

Price negotiations will be staggered over time, beginning with this initial list of ten Part D drugs that takes effect in 2026 (Part D is the prescription drug coverage component of Medicare, a federal health insurance program for people 65 and older which covers nearly 1 in 5 Americans). These ten drugs cost Medicare Part D nearly $46.8

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52

Nixon Gwilt Law

JANUARY 14, 2025

Shortly thereafter, Colorado passed the Colorado AI Act, which, effective January 1, 2026, imposes comprehensive governance and disclosure obligations on developers of high-risk AI systems, which would include many AI systems deployed in healthcare settings.

Healthcare 52

Healthcare Healthcare Food and Drug Administration Government 52

Healthcare Success

JANUARY 27, 2025

Retaining loyal members requires a smart, tailored approach to stay competitive." However, I've heard there are some rumors out there that there are some plans that will be entering the marketplace for 2025 to offer 2026 benefits. And yet, you know, things never seemed to stay the same. 18 exited last year.

Marketing 65

Marketing Education Media Leads 65

Clarivate

OCTOBER 17, 2024

As California Attorney General from 2011 to 2017, Harris was a forceful opponent of healthcare industry consolidation, both vertical and horizontal, believing that mergers of hospitals, physician groups and insurers would damage competition and raise prices for care. 31, 2024, and providers and payers are pushing for an extension.

Healthcare 52

Healthcare Healthcare Government Insurance 52